Literature DB >> 7784718

Hospital mortality after out-of-hospital cardiac arrest among patients found in ventricular fibrillation.

J Herlitz1, L Ekström, B Wennerblom, A Axelsson, A Bång, S Holmberg.   

Abstract

The aim of this study was to describe factors associated with in-hospital mortality among patients being hospitalised after out-of-hospital cardiac arrest and who were found in ventricular fibrillation. The study was set in the community of Göteborg, Sweden. The subjects consisted of all patients who were hospitalised alive after out-of-hospital cardiac arrest, being reached by our mobile coronary care unit and who were found in ventricular fibrillation, between 1981 and 1992. In all, 488 patients fulfilled the inclusion criteria of which 262 (54%) died during initial hospitalization. In a multivariate analysis including age, sex, history of cardiovascular disease, chronic medication prior to arrest and circumstances at the time of arrest, the following appeared as independent predictors of hospital mortality: (1) interval between collapse and first defibrillation (P < 0.001); (2) on chronic medication with diuretics (P < 0.01); (3) age (P < 0.01); (4) bystander initiated CPR (P < 0.05); and (5) a history of diabetes (P < 0.05). In a multivariate analysis considering various aspects of status on admission to hospital, the following were independently associated with death: (1) degree of consciousness (P < 0.001) and (2) systolic blood pressure (P < 0.05). In conclusion, among patients with out of hospital cardiac arrest found in ventricular fibrillation and being hospitalised alive, 54% died in hospital. The in-hospital mortality was related to patient characteristics before the cardiac arrest as well as to factors at the resuscitation itself.

Entities:  

Mesh:

Year:  1995        PMID: 7784718     DOI: 10.1016/0300-9572(94)00811-s

Source DB:  PubMed          Journal:  Resuscitation        ISSN: 0300-9572            Impact factor:   5.262


  6 in total

1.  Protective effects of nitric oxide synthase 3 and soluble guanylate cyclase on the outcome of cardiac arrest and cardiopulmonary resuscitation in mice.

Authors:  Takefumi Nishida; Jia De Yu; Shizuka Minamishima; Patrick Y Sips; Robert J Searles; Emmanuel S Buys; Stefan Janssens; Peter Brouckaert; Kenneth D Bloch; Fumito Ichinose
Journal:  Crit Care Med       Date:  2009-01       Impact factor: 7.598

2.  Effects of mild hypothermia on hemodynamics in cardiac arrest survivors and isolated failing human myocardium.

Authors:  Claudius Jacobshagen; Theresa Pelster; Anja Pax; Wiebke Horn; Stephan Schmidt-Schweda; Bernhard W Unsöld; Tim Seidler; Stephan Wagner; Gerd Hasenfuss; Lars S Maier
Journal:  Clin Res Cardiol       Date:  2010-02-04       Impact factor: 5.460

3.  The association between blood lactate concentration on admission, duration of cardiac arrest, and functional neurological recovery in patients resuscitated from ventricular fibrillation.

Authors:  M Müllner; F Sterz; H Domanovits; W Behringer; M Binder; A N Laggner
Journal:  Intensive Care Med       Date:  1997-11       Impact factor: 17.440

4.  Invasive versus non-invasive cooling after in- and out-of-hospital cardiac arrest: a randomized trial.

Authors:  Undine Pittl; Alexandra Schratter; Steffen Desch; Raluca Diosteanu; Denise Lehmann; Katharina Demmin; Jacqueline Hörig; Gerhard Schuler; Thorsten Klemm; Meinhard Mende; Holger Thiele
Journal:  Clin Res Cardiol       Date:  2013-05-05       Impact factor: 5.460

Review 5.  Association between diabetes mellitus and poor patient outcomes after out-of-hospital cardiac arrest: A systematic review and meta-analysis.

Authors:  Dinesh Chandra Voruganti; Adithya Chennamadhavuni; Rohan Garje; Ghanshyam Palamaner Subash Shantha; Marin L Schweizer; Saket Girotra; Michael Giudici
Journal:  Sci Rep       Date:  2018-12-18       Impact factor: 4.379

6.  Systematic review of the relationship between comorbidity and out-of-hospital cardiac arrest outcomes.

Authors:  David Majewski; Stephen Ball; Judith Finn
Journal:  BMJ Open       Date:  2019-11-18       Impact factor: 2.692

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.